Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg
乌司奴单抗治疗中重度活动性儿童克罗恩病:UNITI Jr 研究在体重至少 40 公斤的患者中的安全性和有效性结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjag011
De Greef, Elisabeth; Turner, Dan; Kierkuś, Jarosław; Korczowski, Bartosz; Meglicka, Monika; Cohen, Stanley A; Hyams, Jeffrey S; Griffiths, Anne M; Rosh, Joel R; Strauss, Richard; Van Limbergen, Els; Adedokun, Omoniyi J; Kim, Lilianne; Volger, Sheri